• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种肿瘤老年综合评估工具(G8、优化 G8 和 CARG)在预测老年癌症患者化疗相关毒性中的性能。一项前瞻性临床研究。

The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.

机构信息

University Cancer Center Leipzig (UCCL), University Hospital Leipzig, Leipzig, Germany.

Haematology and Oncology Department, St. Georg Hospital Leipzig, Leipzig, Germany.

出版信息

J Geriatr Oncol. 2019 Nov;10(6):937-943. doi: 10.1016/j.jgo.2019.04.004. Epub 2019 May 10.

DOI:10.1016/j.jgo.2019.04.004
PMID:31085136
Abstract

BACKGROUND

Older patients are vulnerable to chemotherapy-related toxicity (CRT). Therefore we evaluated screening tools in their power to predict CRT.

METHODS

Patients with cancer aged ≥65 years completed three screening questionnaires (G8, optimised G8 and Cancer and Ageing Research Group (CARG). Additionally, Comprehensive geriatric assessment (CGA) for verification of supportive care needs was undertaken on patients with impaired G8 scores. During chemotherapy treatment patients were assessed, capturing grade 0-5 CRT as defined by NCI CTCAE 4.

RESULTS

104 patients with non-haematological cancers were included at three study sites. Median age was 73 years (range 65-85). Onco-geriatric screening detected 74% as impaired using G8 and optimised G8 questionnaires and 86% using CARG screening. Grade 3-5 toxicity affected 64.4% of all patients. G8 (OR 0.3 95% CI [0.1;1.0]) and optimised G8 (OR 0.4 95% CI [0.1; 1.5]) did not reliably predict CRT, whereas screening with CARG demonstrated a strong prediction of severe CRT: OR 4.2, 95% CI [1.1, 15.9]. CGA was undertaken on 66 patients, revealing deficiencies in nutritional (83%) and functional-status (54%) and occurrence of relevant comorbidity (53%).

CONCLUSION

The CARG tool could be useful for predicting CRT. CGA showed clinically relevant supportive care needs in patients with a positive G8 screening.

摘要

背景

老年患者易发生化疗相关毒性(CRT)。因此,我们评估了这些筛查工具预测 CRT 的能力。

方法

≥65 岁的癌症患者完成了三个筛查问卷(G8、优化 G8 和癌症与老龄化研究小组(CARG)。此外,对 G8 评分受损的患者进行了全面的老年评估(CGA),以验证支持性护理需求。在化疗治疗期间,评估患者,根据 NCI CTCAE 4 定义捕获 0-5 级 CRT。

结果

在三个研究地点共纳入了 104 名非血液系统癌症患者。中位年龄为 73 岁(范围 65-85 岁)。使用 G8 和优化 G8 问卷,74%的患者存在认知障碍,使用 CARG 筛查则有 86%的患者存在认知障碍。所有患者中有 64.4%发生了 3-5 级毒性。G8(OR 0.3,95%CI [0.1;1.0])和优化 G8(OR 0.4,95%CI [0.1;1.5])均不能可靠地预测 CRT,而使用 CARG 筛查则能很好地预测严重的 CRT:OR 4.2,95%CI [1.1, 15.9]。对 66 名患者进行了 CGA,发现存在营养(83%)和功能状态(54%)缺陷以及相关合并症(53%)。

结论

CARG 工具可用于预测 CRT。在 G8 筛查阳性的患者中,CGA 显示出了临床上相关的支持性护理需求。

相似文献

1
The performance of three oncogeriatric screening tools - G8, optimised G8 and CARG - in predicting chemotherapy-related toxicity in older patients with cancer. A prospective clinical study.三种肿瘤老年综合评估工具(G8、优化 G8 和 CARG)在预测老年癌症患者化疗相关毒性中的性能。一项前瞻性临床研究。
J Geriatr Oncol. 2019 Nov;10(6):937-943. doi: 10.1016/j.jgo.2019.04.004. Epub 2019 May 10.
2
Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.前瞻性比较 CARG、G8 和 VES-13 毒性工具在预测土耳其老年癌症患者化疗相关毒性中的价值。
J Geriatr Oncol. 2022 Jul;13(6):821-827. doi: 10.1016/j.jgo.2022.03.004. Epub 2022 Mar 28.
3
The predictive value of G8 and the Cancer and aging research group chemotherapy toxicity tool in treatment-related toxicity in older Chinese patients with cancer.G8及癌症与衰老研究组化疗毒性工具对中国老年癌症患者治疗相关毒性的预测价值。
J Geriatr Oncol. 2021 May;12(4):557-562. doi: 10.1016/j.jgo.2020.10.013. Epub 2020 Oct 27.
4
Predicting chemotherapy toxicity in older adults: Comparing the predictive value of the CARG Toxicity Score with oncologists' estimates of toxicity based on clinical judgement.预测老年人化疗毒性:比较 CARG 毒性评分与肿瘤学家基于临床判断估计毒性的预测价值。
J Geriatr Oncol. 2019 Mar;10(2):202-209. doi: 10.1016/j.jgo.2018.08.010. Epub 2018 Sep 14.
5
Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland.爱尔兰一所三级大学医院对老年癌症患者实施 G8 筛查工具、认知筛查评估和化疗毒性评估的初步研究。
Ir J Med Sci. 2024 Feb;193(1):45-50. doi: 10.1007/s11845-023-03446-y. Epub 2023 Jul 14.
6
Validation of the G8 screening tool in older patients with aggressive haematological malignancies.G8筛查工具在老年侵袭性血液系统恶性肿瘤患者中的验证
Eur J Oncol Nurs. 2014 Dec;18(6):645-8. doi: 10.1016/j.ejon.2014.05.006. Epub 2014 Jun 20.
7
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.G8 和 VES-13 作为老年综合评估的筛查工具及预测印度老年癌症患者生存的指标。
J Geriatr Oncol. 2022 Jun;13(5):720-730. doi: 10.1016/j.jgo.2022.02.013. Epub 2022 Mar 10.
8
Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.老年病学筛查结果与(放)化疗第一周期后严重治疗毒性的关系。
J Geriatr Oncol. 2014 Apr;5(2):179-84. doi: 10.1016/j.jgo.2013.12.004. Epub 2014 Jan 17.
9
Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.使用两种老年评估工具在临床状况良好的老年血液系统恶性肿瘤患者中识别预测一年生存率的临床参数:认知的主要影响
J Geriatr Oncol. 2015 Sep;6(5):362-9. doi: 10.1016/j.jgo.2015.07.006. Epub 2015 Aug 12.
10
Predictive ability of the G8 screening test to determine probable sarcopenia and abnormal comprehensive geriatric assessment in older patients with solid malignancies.G8 筛查试验对确定实体恶性肿瘤老年患者可能发生的肌肉减少症和异常综合老年评估的预测能力。
BMC Geriatr. 2021 Oct 19;21(1):574. doi: 10.1186/s12877-021-02544-9.

引用本文的文献

1
Validation of a Chemotherapy Toxicity Prediction Model in Older Adults With Cancer in Taiwan.台湾老年癌症患者化疗毒性预测模型的验证
Cancer Control. 2025 Jan-Dec;32:10732748251347902. doi: 10.1177/10732748251347902. Epub 2025 Jun 12.
2
Frailty and outcomes in adults undergoing systemic anticancer treatment: a systematic review and meta-analysis.接受全身抗癌治疗的成年人的衰弱状况与预后:一项系统评价和荟萃分析。
J Natl Cancer Inst. 2025 Jul 1;117(7):1316-1339. doi: 10.1093/jnci/djaf017.
3
Assessing Frailty in Gastrointestinal Cancer: Two Diseases in One?
评估胃肠癌中的衰弱:一体多病?
Curr Oncol Rep. 2024 Jan;26(1):90-102. doi: 10.1007/s11912-023-01483-5. Epub 2024 Jan 2.
4
External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort.两种评分预测老年实体瘤患者化疗毒性风险的外部有效性:来自 ELCAPA 前瞻性队列研究的结果。
Oncologist. 2023 Jun 2;28(6):e341-e349. doi: 10.1093/oncolo/oyad050.
5
Frailty and Cancer: Current Perspectives on Assessment and Monitoring.虚弱与癌症:评估和监测的当前观点。
Clin Interv Aging. 2023 Mar 28;18:505-521. doi: 10.2147/CIA.S365494. eCollection 2023.
6
Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study.二线化疗在老年晚期胆道癌患者中的应用:一项多中心真实世界研究。
Medicina (Kaunas). 2022 Oct 27;58(11):1543. doi: 10.3390/medicina58111543.
7
Validity of the Cancer and Aging Research Group Predictive Tool in Older Japanese Patients.癌症与衰老研究组预测工具在老年日本患者中的有效性
Cancers (Basel). 2022 Apr 21;14(9):2075. doi: 10.3390/cancers14092075.
8
Anti-Cancer Treatment Strategies in the Older Population: Time to Test More?老年人群的抗癌治疗策略:是时候进行更多试验了吗?
Geriatrics (Basel). 2021 Apr 15;6(2):42. doi: 10.3390/geriatrics6020042.
9
Utility of the Geriatric 8 for the Prediction of Therapy-Related Toxicity in Older Adults with Diffuse Large B-Cell Lymphoma.老年 8 项用于预测老年弥漫性大 B 细胞淋巴瘤患者治疗相关毒性的效用。
Oncologist. 2021 Mar;26(3):215-223. doi: 10.1002/onco.13641. Epub 2020 Dec 30.
10
Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge Study.癌症老年患者药物重整与综合老年评估相关:ChimioAge 研究。
Clin Interv Aging. 2020 Sep 8;15:1587-1598. doi: 10.2147/CIA.S262209. eCollection 2020.